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Abstract
Background: Approximately 60% of patients presenting to dentists with erosive tooth wear have significant
gastroesophageal reflux (GERD), despite minor reflux symptoms. No longitudinal studies of reflux-associated erosive
tooth wear and of reflux characteristics have been reported to date.
The aim of this study was to characterize the longitudinal course of GERD and of associated erosive tooth wear, as
well as factors predictive of its progression, in a large group of patients.
Methods: Seventy-two patients presenting to dentists with clinically significant erosive tooth wear and increased
esophageal acid exposure by 24-h multichannel intraluminal pH-impedance measurement (MII-pH) were re-
assessed clinically and by MII-pH after 1 year treatment with esomeprazole 20 mg twice-daily. Predictive factors for
erosive tooth wear were assessed by logistic regression.
Results: At follow-up, no further progression in erosive tooth wear was observed in 53 (74%) of patients. The
percentage of time with a pH < 4, the number of acid reflux episodes and the percentage of proximal esophageal
reflux off-PPI did not change significantly after one year, but the number of weakly acidic reflux episodes decreased
significantly in the large subgroup without progression. None of the baseline demographic, clinical, endoscopic or
esophageal acid exposure characteristics were significantly associated with progression of erosive tooth wear at
follow-up.
Conclusions: In this longitudinal study in patients with erosive tooth wear and oligosymptomatic GERD receiving
esomeprazole for one year, erosive tooth wear did not progress further in the majority of patients. Background
acidic esophageal reflux exposure appeared stable over time, whereas weakly acidic exposure decreased
significantly in patients without erosion progression. MII-pH measurements on-PPI and with healthy controls will be
useful in the further elucidation of the causal role of reflux in erosive tooth wear.
Trial registration: ClinicalTrials.gov, retrospectively registered: NCT02087345.
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Background
Dental erosion, the chemical dissolution of enamel with-
out bacterial involvement, is considered an established
complication of gastroesophageal reflux (GERD) [1]. It is
caused by repeated episodes of exposure to acid and is
influenced by chemical (e.g. salivary buffering effects,
pH, fluoride,) and physical (temperature, flow rate) fac-
tors [2]. As dental erosion commonly occurs in
conjunction with abrasive processes, it is now termed
“erosive tooth wear” [3]. Advanced erosive tooth wear
leads to functional compromise, oral symptoms and dis-
figurement. The reported prevalence erosive tooth wear
varies between 17% and 68% in patients with symptom-
atic GERD and a recent study of erosive tooth wear re-
vealed a prevalence of 29% in 3187 European adults
aged 18–35 years without symptomatic GERD [4, 5]. Re-
cently, characterisation of reflux by 24-h multichannel
intraluminal pH-impedance measurements (MII-pH)
and endoscopy in a large prospective cohort of oligo-
symptomatic patients presenting with erosive tooth wear
to dentists was published, showing significant
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gastroesophageal reflux in the majority [5]. This further
substantiated the frequent association between GERD
and erosive tooth wear, after exclusion of other causes of
erosion, such as frequent vomiting, increased ingestion
of acidic food or drink and bruxism. Once erosive tooth
wear is established, prevention of further loss of dental
tissue is important, not only because of the high cost of
the necessary dental work, but also because of the com-
mon sequelae of oral hypersensitivity, functional and
aesthetic impairment. Once clinically manifest, erosive
tooth wear is currently not reversible. To the best of our
knowledge, no systematic study relating to the preven-
tion of progression of erosive tooth wear caused by
GERD has been reported, except a small pilot project
examining optical coherence tomography as a tool for
quantifying dental reflux damage [6]. As no reliable local
preventive treatment exists, our centre has in the past
arbitrarily recommended long-term proton pump inhibi-
tor (PPI) dosing. In this article we present single-centre,
follow-up data regarding GERD characteristics using
MII-pH and erosive tooth wear progression in a large
cohort of patients receiving standardised PPI treatment,
based on the hypothesis that reflux would not signifi-
cantly change over time and that standard PPI doses
would prevent further progression of erosions. Predictive
factors for the progression of erosions were additionally
investigated.
Methods
Consecutive patients presenting at the Department of
Preventive, Restorative and Pediatric Dentistry of the
University of Bern and affiliated dentists with an erosive
tooth wear score greater than 8 (BEWE: Basic Erosive
Tooth Wear Examination) – see below for definition),
were referred to the Gastroenterology Group Practice
between 1/2010 and 12/2012 for evaluation of GERD
after exclusion of non-reflux causes of erosion by de-
tailed medical history, dental examination, a standard-
ized dietary diary, and measurement of salivary flow and
buffering capacity using standard procedures [7, 8]. Pa-
tients with a history of bruxism, eating disorders, recur-
rent vomiting, severe obesity (body mass index
(BMI) > 35 kg/m2) or past bariatric surgery (both be-
cause of the likelihood of representing a specialized sub-
group of GERD), and dietary or primarily abrasive
causes for erosive tooth wear were excluded. All patients
were seen by a dedicated team of dentists experienced in
the diagnosis of erosion and the severity of erosion was
graded using the BEWE [7]. The BEWE is a simple cu-
mulative scoring system quantifying the size of a given
lesion as a percentage of the surface affected. The ves-
tibular, occlusal and palatal surfaces of all teeth except
third molars are graded. The dentition is divided into
sextants, the most severe score in a sextant is recorded
and the cumulative score from all sextants (max-
imum = 18) represents the index value. Further, high-
quality photographs of the teeth were examined and the
findings recorded (Fig. 1). Upon referral, every patient
was examined by the same senior gastroenterologist
(CWS), reflux symptoms were assessed by interview and
the Reflux Disease Questionnaire and esophago-gastro-
duodenoscopy with gastric and, if clinically indicated,
esophageal biopsies, and subsequent 24-h oesophageal
MII-pH (Ohmega, MMS, Enschede, Holland) were per-
formed [9].The single-use MII-pH catheter (pHersaflex,
Sierra Scientific Instruments, Los Angeles, USA) with
impedance measurement sites at 3, 5, 7, 9, 15 and 17 cm
and a distal pH-sensor at 5 cm above the lower
oesophageal sphincter was introduced transnasally after
an overnight fast and placed with the pH sensor at 5 cm
proximal to the oesophago-gastric junction. Patients
were instructed to perform their normal daily activities,
eat and drink as usual, and document the times at which
they lay down, ate and drank or experienced reflux
symptoms using the datalogger’s event markers. Patients
on antisecretory medication discontinued their dosing
14 days before the MII-pH recording. The numbers of
all (pH < 7), acidic (pH < 4) and weakly acidic (pH >4
and <7) reflux episodes, the percentage time with pH < 4
and <5.5, the percentage of proximal reflux episodes
(reaching 15 cm above the gastroesophageal junction) in
the total 24 h, the DeMeester score and the symptom as-
sociations by symptom association probability (SAP)
>95% were analyzed [9, 10]. Patients with a pH < 4 for
more than 5% of the measurement period or more than
75 total (acidic plus weakly acidic), 50 acidic and 33
weakly acidic reflux episodes at 5 cm and more than 30
total reflux episodes at 15 cm above the gastroesopha-
geal junction were considered to have increased reflux
based on normal European values published by Zerbib
et al. [11].
Patients with increased reflux at the first work-up re-
ceived prescriptions for esomeprazole 20 mg tablets
(AstraZeneca AG, Zug, Switzerland), to be taken 10–
20 min before breakfast and dinner. This dose was
chosen as the most effective PPI dosing regimen based
on published pharmacodynamic data [12, 13]. These pa-
tients were recalled for the same detailed dental assess-
ment as outlined above within 2 years. Compliance with
the treatment was assessed by verbal interview and was
rated as high (dose missed on average less than once per
week), moderate (dose missed between once and three
times per week) or poor (dose missed more than three
times per week). Patients were also questioned about
any adverse events they had experienced during treat-
ment with the PPI.
This was a study analyzing coded clinical data with no
additional research-related procedures for which no
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Cantonal Ethics Committee approval or written in-
formed consent were required in Switzerland at the
time, until the institution of the Human Research Law
(Humanforschunggesetz) after 1.2014. The study was
conducted according to the principles of the 1964 Dec-
laration of Helsinki and its later amendments and pa-
tients provided verbal informed consent.
Statistical analysis
Analyses were performed with the statistical Software R,
Version 3.0.1 (http://www.R-project.org, Revolution An-
alytics, Vienna, Austria) by the biostatistical co-author.
The means and 95% confidence intervals of normally
distributed variables, and medians and interquartile
ranges of non-normally distributed or non-continuous
data are shown. Erosion progression at follow-up within
the first 2 years was the target value and was defined as
an increased BEWE score compared to baseline. Pro-
gression was assessed as either ‘yes’ or ‘no’, and therefore
was a dichotomous value. We assessed the impact of the
following baseline describing values on the target value:
gender, age, GERD symptoms less or more than twice a
week, the presence of a hiatal hernia, the percentage of
reflux episodes reaching the proximal oesophagus, the
BEWE score, the percentage of time with pH < 4 and
<5.5, the DeMeester score and the numbers of acidic
and weakly-acidic reflux episodes. The impact of the di-
chotomous describing values, namely gender, GERD
symptoms and the presence of a hiatal hernia, was
assessed using Fisher’s exact test. The impact of the
above metric variables was assessed using a logistic re-
gression model. Multiple testing was corrected for using
Holm’s methodology. Between group comparisons of
MII-pH data were performed with the Mann Whitney U
test for non-parametric and the t-test for parametric
variables.
Results
During the recruitment period 161 patients presenting
with erosive tooth wear underwent baseline work-up as
described in the Methods section. 141 of the 161 pa-
tients (88%) included in the baseline work-up had in-
creased esophageal acid exposure compared to
published normal values [11]. 72 of the 161 patients
(45%) had increased reflux and returned for the sched-
uled follow-up within 2 years. Of the 89 patients ex-
cluded from the study, 19 had a normal MII-pH analysis
at baseline and 70 patients with an abnormal MII-pH at
baseline were excluded for the following reasons: 49 had
a change of dentist or the dentist failed to provide com-
parative erosion data, 13 patients were lost to follow-up
and could not be contacted and 8 patients refused the
follow-up examination. There were no statistically sig-
nificant differences in baseline demographics, GERD
characteristics or MII-pH results between those patients
who qualified for follow-up but dropped out versus
those who completed follow-up. Seventy-two patients
with erosive tooth wear and abnormal reflux at baseline
were therefore included in this longitudinal analysis.
Their characteristics are summarized in Table 1. Fifty-
nine of the patients were assessed 1 year after the base-
line assessment, one patient after 7 months and 12 pa-
tients after 2 years.
Fig. 1 Typical high-resolution photographs of dental erosions secondary to gastroesophageal reflux. a Oral (BEWE 3). b Occlusal (BEWE 3).
BEWE = basal erosive wear examination [7]
Table 1 Baseline characteristics of 72 patients presenting with
dental erosion and treated with esomeprazole 20 mg twice-
daily
Gender: male/female (n) 52 / 20
Age: years# 33.8 (29.1–38.5)
Patients with GERD symptoms >2 per week (n) 15
Reflux Disease Questionnaire score+ 3 (1–5)
Patients previously using PPI regularly (n) 0
Patients with endoscopic hiatal hernia (n) 12
BEWE score+ 14 (11–17)
Median follow-up time+ 1 (1–1)
BEWE Basic erosive wear examination [7]. (9–13 medium, >13 extensive erosive
disease), GERD gastrooesophageal reflux disease, PPI proton pump inhibitor.
#means (95% confidence intervals) + median (interquartile range)
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No progression of erosive tooth wear was observed in
53 of the 72 patients (74%), while progression was seen
in 19 (26%) within the follow-up period with esomepra-
zole treatment. None of the baseline demographic, clin-
ical, endoscopic or 24 h–MII-pH characteristics were
significantly associated with progression of erosive tooth
wear at follow-up.
The MII-pH data at baseline and at follow-up after a
median interval of 1 year are shown in Table 2. The per-
centage of time with reflux below thresholds of pH 4
and 5.5, and the percentage of proximal esophageal re-
flux were not significantly different from baseline after
1 year. However, the number of weakly acidic reflux epi-
sodes was significantly decreased at follow-up, explain-
ing the reduction in the number of all reflux episodes.
These decreases from baseline were significant in the
subgroup of patients with no progression of erosion, but
did not reach significance in the smaller subgroup of pa-
tients with progression of erosions. Analysis of the cor-
relation between symptoms and reflux episodes during
MII-pH by SAP, SII and SI was not relevant, as 86% of
patient did not report reflux symptoms during MII-pH.
No significant adverse events necessitating discontinu-
ation of esomeprazole were noted. Compliance was rated
high in 86% of patients, moderate in 12% and poor in
2%.
Discussion
This longitudinal 1-year study characterized the course
of erosive tooth wear and of gastroesophageal reflux by
MII-pH in patients initially presenting to dentists. It cor-
roborates earlier data showing the high prevalence of
oligosymptomatic reflux (88% in this study) in patients
presenting to dentists with erosive tooth wear [5]. Ap-
proximately 80% of these patients do not complain of
relevant reflux symptoms. The course of established ero-
sive tooth wear over time is relatively unknown, espe-
cially in patients with proven GERD.
The current investigation aimed to provide further in-
formation in this little-studied group of patients. Erosive
tooth wear progressed in 26% of our adult patients with
GERD after a median follow-up of one year. Esomepra-
zole was prescribed to all patients at baseline for preven-
tion of progression of erosive tooth wear, as no
treatment guidelines have thus far been formulated. The
absence of further progression of erosion during active
GERD may be due to several factors. These include the
protective anti-secretory action of the PPI, a spontan-
eous decrease in reflux (natural history), or an associ-
ation with unrecognized factors other than acid reflux,
for example, abnormalities in the saliva. A few prospect-
ive studies in healthy adolescents, i.e. without known
GERD, describe progression of erosion in between 3.5%
and 18% patients annually, and in 27% and 56% after 2
to 4 years using various clinical grading scales and meth-
odologies [14–17]. In a prospective study using silicone
impressions, over 70% of subjects had progressive tooth
substance wear of over 15 μm (accuracy threshold of
measurement, but unknown relationship to visual BEWE
scoring) over a 6-month period. This was a mixed co-
hort of subjects, including some individuals with symp-
tomatic reflux [18]. These cohorts cannot be used as
direct controls; however, the erosion progression in
healthy controls appears considerably lower than in our
group with proven GERD. It is evident, that some pro-
gressive loss of tooth substance is normal with ageing
Table 2 Twenty-four-hour ambulatory multichannel pH-impedance measurement results and BEWE scores at baseline and at follow-
up off-PPI in patients with progression or no progression of dental erosion after a median of 1 year treatment with esomeprazole
20 mg twice-daily. Means and 95% confidence intervals are shown
At baseline At follow-up
All patients
N = 72
All patients
N = 72
No erosion progression
N = 53
Erosion progression
N = 19
% time with pH < 4a 16.5 (12.6–20.4) 11.7 (5.7–17.7) 10.2 (6.7–13.7) 16.9 (6.4–27.4)
% time with pH < 5.5a 43.5 (33.3–53.7) 40.2 (31.1–49.3) 40.5 (26.6–54.4) 37.7 (26.6–48.8)
DeMeester scorea 56.4 (43.2–69.6) 46.3 (34.3–54.3) 41.7 (31.8–51.6) 69.1 (40.1–98.1)
Number of all reflux episodes (pH < 7)b 85 (64–106) 52 (41–63)* 53 (46–61)** 52 (33–71)
Number of acidic reflux episodes (pH < 4)b 54 (41–67) 41 (31–50) 43 (37–49) 33 (24–42)
Number of weakly acidic reflux episodes (pH > 4–
pH < 7)b
31 (24–38) 12 (8–18)** 10 (8–12)** 19 (10–28)
% proximal reflux (15 cm above lower oesophageal
sphincter)a
26 (20–32) 23 (17–29) 23 (19–27) 21 (15–27)
BEWE scoresb 12 (11–16) 13 (12–15) 12 (11–13) 14 (13–16)***
BEWE Basic erosive wear examination (9–13 medium, >13 extensive erosive disease) [7]
ameans (95% confidence intervals)
bmedian (interquartile range)
*p < 0.05 versus baseline **p < 0.01 versus baseline ***p < 0.01 group with erosion progression vs group without erosion progression
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and that this loss is more likely to occur in bursts than
at a constant rate [18]. One underlying cause of such
bursts may well be GERD.
There is also little data on the natural history of silent
or primarily supra-esophageal reflux, although using
clinical and endoscopic assessments, symptomatic GERD
appears to be a chronic and stable disease, with regres-
sion in the severity of manifestations occurring in a mi-
nority of patients [19–22]. This observation is, however,
of limited applicability to oligosymptomatic patients, and
relevant longitudinal MII-pH data is lacking. In the
current study acidic reflux characterized by MII-pH was
stable and did not differ between patients with and with-
out erosive tooth wear progression. However, weakly
acidic acid exposure fluctuated considerably over time,
showing a significant decrease at follow-up in the entire
group of patients and in the large subgroup without ero-
sion progression. There was also a corresponding clear
trend in patients with erosion progression, but due to
the smaller sample size, significance compared to base-
line was not attained. Consequently, esophageal expos-
ure to weakly acidic refluxate fluctuates more than to
acidic refluxate with a pH below 4. Nonetheless, this
background fluctuation in the natural history of GERD
is unlikely to explain the absence of erosion progression
in a subgroup of patients. It should be noted that the re-
peatability of MII-pH has been examined and is improb-
able as an explanation of the variation in acid exposure
[11].
None of the baseline demographic, endoscopic or acid
exposure characteristics predicted subsequent progres-
sion of erosive tooth wear. This implies that baseline
characteristics do not predict the response of erosive
tooth wear to the PPI treatment, but this could only be
confirmed by the inclusion of a control group without
treatment, which is very difficult for ethical reasons.
Interestingly, clinical variables and acid exposure charac-
teristics by MII-pH reflux variables also do not signifi-
cantly predict the symptomatic response to PPI’s in
GERD, as shown by Zerbib et al. [23]. This suggests that
factors other than refluxed acid alone, such as proteases
and bile in refluxate or non-reflux associated factors,
may play a prominent role in erosive tooth wear. A MII-
pH study during PPI treatment would provide further
relevant information on the longitudinal relationship be-
tween erosion progression and reflux.
The major limitation of this study is the absence of an
untreated control group, which had in a related, earlier
study been considered unethical by the responsible re-
view board. An inherent methodological limitation in all
in vivo dental studies is the detailed quantification of
erosive tooth wear. However, the best possible
standardization of dental evaluations was achieved by
having the same dentist from a highly specialized
university department assess the same patient at baseline
and follow-up, using the recently defined BEWE scoring
system as well as high-resolution photography. The
BEWE is a scoring system with three severity grades.
Minor increases in erosion are less likely to be reflected
in the scores, or, indeed, to be detected visually. Infor-
mation on the smoking or alcohol consumption, further
confounders in GERD studies, was not available in this
study.
Conclusions
In summary, after a median follow-up of one year, ero-
sive tooth wear did not progress further in 74% of pa-
tients with erosive tooth wear and oligosymptomatic
GERD receiving esomeprazole. Baseline demographic,
clinical and MII-pH date were not predictive of progres-
sion of erosive tooth wear. Background acidic esophageal
reflux exposure appeared stable over time, whereas
weakly acidic exposure decreased significantly in patients
without erosion progression. MII-pH measurements on-
PPI and with healthy controls are required to further
examine the causal role of reflux in dental erosion.
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